
Renokinase 500000IU Injection
Marketer
Biosena Lifescience
Salt Composition
Urokinase (500000IU)
Overview Renokinase 500000IU Injection
Thrombolytic therapy with Renokinase 500000IU Injection dissolves dangerous blood clots obstructing blood vessels. This medication treats acute myocardial infarction (heart attack) and is indicated for pulmonary embolism and ischemic stroke. Administration requires medical oversight; dosage and treatment length are determined by your physician, who will monitor your recovery. Potential side effects include nausea, vomiting, injection site hemorrhage, hypersensitivity reactions, and hypotension. Increased bleeding risk exists. Your doctor will discuss the risks and benefits before treatment. Continue all prescribed medications concurrently. Caution is advised for patients with bleeding disorders, hepatic or renal impairment, pregnancy, breastfeeding, or those taking other medications; full disclosure to your physician is essential.
Primary Ingredients of Renokinase 500000IU Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Renokinase 500000IU Injection
Myocardial infarction | Pulmonary thromboembolism
Major Benefits of Renokinase 500000IU Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Renokinase 500000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Renokinase 500000IU Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Renokinase 500000IU Injection works:
Fibrinolytic therapy with Renokinase 500000IU injection breaks down dangerous thrombi within the vasculature. This action re-establishes perfusion to compromised tissues, mitigating ischemic injury and improving patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Renokinase 500000IU Injection lacks established safety data. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Renokinase 500000IU Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Renokinase 500000IU Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingNOT RELEVANT
Irrelevant, given that Renokinase 500000IU Injection is administered only in a hospital setting.
KidneySAFE IF PRESCRIBED
The use of 500,000 IU Renokinase injections in patients with kidney disease appears to present a low risk. Available evidence indicates that dose modification might not be necessary; however, medical consultation is advised. Renokinase 500,000 IU injections are contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver conditions should use Renokinase 500000IU Injection cautiously; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Renokinase 500000IU Injection :
Omit a Renokinase 500000IU Injection dose? Seek your physician's advice.
Facts to Know About Renokinase 500000IU Injection
| Label | Value |
|---|---|
| Chemical Category | Amino acid and peptide analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Early Thrombolytic Agents |
